Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valganciclovir Dosing in Pediatric SOT Recipients
NCT02503982Phase 4Completed
- Sponsor
- Rabin Medical Center
- Start
- Dec 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of valganciclovir in cytomegalovirus infection (CMV), sponsored by Rabin Medical Center. Primary endpoint: Area Under the Curve at Day 4. Started Dec 2014; status: completed.
02
Drugs
valganciclovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT02503982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02503982.